The Precision Epigenomics Liquid Biopsy Test, EPISEEK is a blood-based test designed to accurately assess DNA shed by tumors called circulating tumor DNA (ctDNA) to detect cancer from a simple blood draw.

​

We analyze epigenomic modifications present on the ctDNA. Special software is used to analyze the results and aids the pathologist to issue a report that specifies if an abnormal signal is detected or if no cancer signal is detected